Jan 22 (Reuters) - Omeros Corp:
* EUROPEAN MEDICINES AGENCY ISSUES ORPHAN DRUG DESIGNATION POSITIVE OPINION FOR OMEROSâ€™ OMS721 IN THE TREATMENT OF IGA NEPHROPATHY
* OMEROS CORP - EMA ALSO REVIEWING PRIORITY MEDICINES APPLICATION FOR DRUG IN IGAN
* OMEROS CORP - POSITIVE OPINION ISSUED BY COMP IS EXPECTED TO BE ADOPTED BY EUROPEAN COMMISSION AT ITS FEBRUARY MEETING Source text for Eikon: Further company coverage:
 